Protective effects of a next-generation nutraceutical against amoxicillin/clavulanic acid-induced intestinal dysbiosis
This study evaluated the effects of a next-generation nutraceutical containing Limosilactobacillus fermentum, quercetin, and resveratrol administered before, during, and after treatment with amoxicillin/clavulanic acid in an in vitro colonic fermentation model.